Results 251 to 260 of about 102,788 (290)
Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia [PDF]
Chronic lymphocytic leukemia (CLL) is the most frequent form of leukemia in the Western hemisphere.1 In this disease, a clonal proliferation of neoplastic B lymphocytes accumulates in bone marrow, blood, lymph nodes, liver, and spleen. According to the World Health Organization (WHO) classification, B-cell CLL is a mature (peripheral) B-cell neoplasm ...
Michael L. Grossbard, Ilan Shapira
openaire +2 more sources
Targeting B-cell anergy in chronic lymphocytic leukemia [PDF]
Key Points A sizable fraction of CLL patients is characterized by the expansion of clonal B cells with anergic features. The constitutive biochemical signature of B-cell anergy can be efficiently targeted in CLL for therapeutic purposes.
Apollonio B+10 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Origin of B-Cell Chronic Lymphocytic Leukemia
Seminars in Oncology, 2006An immunobiologic approach has led to substantial changes in our current view of chronic lymphocytic leukemia (CLL). Several questions remain unsolved and the definition of the cell origin of CLL is still prominent. The presence of somatic mutations of IGHV genes indicates that, at least in a portion of cases, CLL cells had encountered an antigen ...
GHIA , PAOLO PROSPERO+1 more
openaire +3 more sources
Cytokines in B-Cell Chronic Lymphocytic Leukemia
Leukemia & Lymphoma, 1991The pleomorphic action of different cytokines in regulating the growth and proliferation of normal B- and T-lymphocyte populations is becoming progressively more apparent. Thus, the possibility that some cytokines, either alone or in variable combination, may play a role in different lymphoproliferative disorders has been increasingly suggested and ...
FOA, Roberto+7 more
openaire +4 more sources
Histopathology of B-cell chronic lymphocytic leukemia
Hematology/Oncology Clinics of North America, 2004Histologic and immunohistologic findings of B-cell chronic lymphocytic leukemia/small lymphocytic leukemia are revised in the light of the more recent knowledge on the pathobiology of the disease. The guidelines for the optimal handling of the bioptic samples are provided. The relevance of the examination of trephines and surgical specimens is outlined
PILERI, STEFANO+6 more
openaire +3 more sources
Rituximab in B-Cell chronic lymphocytic leukemia
Seminars in Oncology, 2003The monoclonal anti-CD20 antibody rituximab exerts its antitumor activity through a variety of mechanisms, including acting against the cellular defects in apoptosis that give rise to B-chronic lymphocytic leukemia (B-CLL). Phase II clinical studies demonstrated that rituximab, given weekly as a single agent, exhibits significantly less activity in B ...
Thomas S. Lin+2 more
openaire +3 more sources
Chronic Myelomonocytic Leukemia Coexisting with B-cell Chronic Lymphocytic Leukemia
Leukemia & Lymphoma, 2003Coexistence of B-cell chronic lymphocytic leukemia (B-CLL) and chronic myelomonocytic leukemia (CMML) is an unusal event, and to our knowledge, only four such cases have been reported in the literature. We report a 68-year-old white woman in whom these two diseases were diagnosed concomitantly.
Ewa Wawrzyniak+6 more
openaire +2 more sources